JPS60256464A - Membrane type serum sampling system and method - Google Patents
Membrane type serum sampling system and methodInfo
- Publication number
- JPS60256464A JPS60256464A JP59112453A JP11245384A JPS60256464A JP S60256464 A JPS60256464 A JP S60256464A JP 59112453 A JP59112453 A JP 59112453A JP 11245384 A JP11245384 A JP 11245384A JP S60256464 A JPS60256464 A JP S60256464A
- Authority
- JP
- Japan
- Prior art keywords
- blood
- plasma
- anticoagulant
- model
- separator
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000012528 membrane Substances 0.000 title claims description 22
- 238000000034 method Methods 0.000 title claims description 13
- 238000005070 sampling Methods 0.000 title claims description 9
- 210000002966 serum Anatomy 0.000 title claims description 4
- 210000004369 blood Anatomy 0.000 claims description 86
- 239000008280 blood Substances 0.000 claims description 86
- 239000003146 anticoagulant agent Substances 0.000 claims description 29
- 229940127219 anticoagulant drug Drugs 0.000 claims description 29
- 210000003462 vein Anatomy 0.000 claims description 11
- 239000002504 physiological saline solution Substances 0.000 claims description 5
- 230000017531 blood circulation Effects 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 229920005597 polymer membrane Polymers 0.000 claims description 2
- 239000011148 porous material Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 231100000957 no side effect Toxicity 0.000 description 3
- 229920002284 Cellulose triacetate Polymers 0.000 description 2
- 206010008531 Chills Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 2
- 230000010100 anticoagulation Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 239000005038 ethylene vinyl acetate Substances 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 239000012510 hollow fiber Substances 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- YKGYIDJEEQRWQH-UHFFFAOYSA-N 4-[6-(diaminomethylideneamino)-1-oxohexoxy]benzoic acid ethyl ester Chemical compound CCOC(=O)C1=CC=C(OC(=O)CCCCCN=C(N)N)C=C1 YKGYIDJEEQRWQH-UHFFFAOYSA-N 0.000 description 1
- 229920001747 Cellulose diacetate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000004019 antithrombin Substances 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229950000501 gabexate Drugs 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
く技術分野〉
本発明は、供血者からの採血に際し、模型血漿分離器を
用いて血液から血漿のみを分離・採取し、同時に乏血漿
の血液を供血者に返還する模型採漿システムおよび成型
採漿法に関するものである。[Detailed Description of the Invention] Technical Field> The present invention uses a model plasma separator to separate and collect only plasma from blood when blood is collected from a donor, and at the same time returns plasma-poor blood to the donor. The present invention relates to a model sample collection system and molded sample collection method.
〈従来技術〉
従来、採漿法としては、遠心分離器を用いて体外流出の
血液から血漿を分離・採取する採漿1(法がある。しか
し、高価な設備を必要とするので不経済であること、採
漿中の体外循環血液量が多いこと、採漿および返血に長
時間を要するること、悪寒・戦慄、低血圧のごとき副作
用の、心配があること、分離血漿中に血小板、血球片、
のどとき不純物を含有し易いことなどの問題を有する。<Prior art> Conventionally, as a plasma sampling method, there is a plasma sampling method (method 1) in which plasma is separated and collected from extracorporeal blood using a centrifuge. However, it is uneconomical because it requires expensive equipment. The amount of extracorporeally circulating blood during plasma collection is large, the long time it takes to collect and return blood, and there are concerns about side effects such as chills, shivering, and hypotension. blood cell fragments,
It has problems such as the fact that it tends to contain impurities in the throat.
〈目的〉′)
本発明は、膜分離法において採漿と返血とを同時に行な
う方式を採用することにより上記の問題点を解決した模
型採漿システムおよび成型採漿法の提供を目的とするも
のであり、本発明によれば、経済性にすぐれ、採漿中の
体外循環血液量が少なく、採漿・返血時間が短かく、副
作用もなく、且つ、純粋な分離血漿が得られる利点を有
する。<Purpose>') The purpose of the present invention is to provide a model plasma collection system and a molded plasma collection method that solve the above problems by adopting a method in which plasma collection and blood return are performed simultaneously in the membrane separation method. According to the present invention, the advantages are that it is highly economical, the amount of extracorporeal circulating blood during plasma collection is small, the plasma collection and blood return time is short, there are no side effects, and pure separated plasma can be obtained. has.
〈実施例〉 本発明のシステムの実施例を図面に基いて・説明する。<Example> An embodiment of the system of the present invention will be described based on the drawings.
第1図および第2図は、本発明の模型採漿システムの流
路系を示すものであり、本発明のシ 2、トチ・は、静
脈に穿刺して血液を体外に流出す 1゛る採血留置針、
体外に流出した血液に抗凝血剤を添加して抗凝血化血液
とする抗凝血剤混合部、該抗凝血化血液から血漿を分離
する模型血漿分離器、該模型血漿分離器にて血液から分
離された血漿を捕集する血漿容器、別の静脈に穿刺して
乏血漿の血液を体内に退入する返血留置針、模型血漿分
離器から血漿容器に血漿を導入する血漿導入路、並びに
、採血留置針・抗凝血剤混合器・模型血漿分離器・返血
留置針の順序に連通ずる血液回路からなることを特徴と
する。Figures 1 and 2 show the flow path system of the model plasma sampling system of the present invention. blood sampling indwelling needle,
An anticoagulant mixing unit that adds an anticoagulant to blood that has flowed out of the body to make anticoagulated blood, a model plasma separator that separates plasma from the anticoagulated blood, and a model plasma separator that A plasma container that collects plasma separated from blood, a blood return indwelling needle that punctures another vein and withdraws plasma-poor blood from the body, and a plasma infusion device that introduces plasma from a model plasma separator into a plasma container. The device is characterized by a blood circuit that communicates with a blood collection indwelling needle, an anticoagulant mixer, a model plasma separator, and a blood return indwelling needle in this order.
本発明に用いられる採血留置針は、静脈に穿刺して血液
を10〜100 tttl/分の流量にて体外に流出す
るものであり、金属製またはプラスチック製の留置針あ
るいは翼状針、が使用できる。The blood collection indwelling needle used in the present invention punctures a vein and blood flows out of the body at a flow rate of 10 to 100 tttl/min, and a metal or plastic indwelling needle or a winged needle can be used. .
本発明に用いられる抗凝血剤混合部は、体外に流出した
血液に、クエン酸ナトリウム液、ヘパリン、プロスタグ
ランディン、ガベキセート・メシレート、抗トロンビン
剤のごとき抗凝血剤を適量添加して抗凝血化血液とする
ものであり、例えば第2図に示すとおり、所要流量の抗
凝血剤を血液に導入・添加する抗凝血剤導入ポンプ、お
よび体外に流出した血液と添加した抗凝血剤とを混合し
て抗凝血化血液として模型血漿分離器へ導入する混合器
からなり、該混合器において抗凝血化血液の流量監視お
よび必要ならば抗凝血化血液を行なって抗凝血剤導入ポ
ンプの流量を調節することができる。The anticoagulant mixing unit used in the present invention adds an appropriate amount of anticoagulants such as sodium citrate solution, heparin, prostaglandin, gabexate mesylate, and antithrombin to the blood that has flowed out of the body. For example, as shown in Figure 2, there is an anticoagulant introduction pump that introduces and adds a required flow rate of anticoagulant to the blood, and an anticoagulant introduction pump that introduces and adds the anticoagulant to the blood that flows out of the body and the added anticoagulant. It consists of a mixer that mixes anticoagulated blood with blood agents and introduces it as anticoagulated blood into a model plasma separator.The mixer monitors the flow rate of anticoagulated blood and, if necessary, performs anticoagulation to remove anticoagulated blood. The flow rate of the coagulant introduction pump can be adjusted.
本発明に用いられる模型血漿分離器は、膜分離により抗
凝血化血液から血漿を分離するものであり、膜材料とし
ては、セルロースジアセテート膜、セルローストリアセ
テート膜のごとき半合成高分子膜、ポリオレフィン膜、
ポリアクリレート膜、ポリビニル膜、ポリカーボネ一ト
膜、ポリスルホン膜のごとき合成高分子膜を挙げられ、
0.1−1ミクロンの膜孔径を有する高分子膜が好適で
ある。膜形状としては、中空゛基型、平膜型、チューブ
型などが挙げられるが、とくに中空糸型が好適である。The model plasma separator used in the present invention separates plasma from anticoagulated blood by membrane separation, and membrane materials include semi-synthetic polymer membranes such as cellulose diacetate membranes and cellulose triacetate membranes, and polyolefin membranes. film,
Examples include synthetic polymer membranes such as polyacrylate membranes, polyvinyl membranes, polycarbonate membranes, and polysulfone membranes.
Polymer membranes with membrane pore sizes of 0.1-1 microns are preferred. Examples of the membrane shape include a hollow base type, a flat membrane type, and a tube type, with a hollow fiber type being particularly suitable.
該模型血漿分離器にて血液から分離された血漿は血漿容
器に捕集される。血漿容器としては、血液バッグ形式の
容器(例えば、エチレン−酢酸ビニルコポリマーシート
製)が好適であり、取扱が便利である。Plasma separated from blood in the model plasma separator is collected in a plasma container. As the plasma container, a blood bag type container (for example, made of ethylene-vinyl acetate copolymer sheet) is suitable and is convenient to handle.
本発明に用いられる返血留置針は、別の静脈に穿刺して
乏血漿の血液を直接に体内に返還するものであり、金属
製またはプラスチック製の留置針あるいは翼状針が使用
できる。The blood return indwelling needle used in the present invention punctures another vein to directly return plasma-poor blood into the body, and can be a metal or plastic indwelling needle or a winged needle.
本発明に用いられる血漿導入路は、模型血漿分離器の血
漿出口から血漿容器に分離血漿を導入するものであり、
王として軟質プラスチックチューブからなる。必要なら
ば血漿ポンプを血漿導入路の中間に配置することができ
、血漿流量力よび分離膜圧を調節することができる。The plasma introduction path used in the present invention introduces separated plasma from the plasma outlet of the model plasma separator into the plasma container,
Made of soft plastic tube as king. If necessary, a plasma pump can be placed in the middle of the plasma introduction path, and the plasma flow force and separation membrane pressure can be adjusted.
本発明に用いられる血液回路は、採血留置針、抗凝血剤
混合器、模型血漿分離器、返血留置針の順序に連通ずる
ものであり、王として軟質プラスチックチューブからな
る。The blood circuit used in the present invention is connected in this order to a blood collection indwelling needle, an anticoagulant mixer, a model plasma separator, and a blood return indwelling needle, and consists mainly of a soft plastic tube.
本発明においては、第2図に示すとおり、膜ジ 型血漿
分離器と返血留置針との間に、補充液ポンプおよび必要
ならば補充液加温器からなり、血漿導入路における血漿
流量のO〜0.5倍の流量の生理食塩水を、乏血漿の血
液に導入・混合できる補充液導入部を設け、乏血漿の血
液の粘度を下げることもできる。In the present invention, as shown in FIG. 2, a replenisher pump and, if necessary, a replenisher warmer are installed between the membrane di-type plasma separator and the blood return indwelling needle to control the plasma flow rate in the plasma introduction path. It is also possible to lower the viscosity of plasma-poor blood by providing a replenisher introduction section that can introduce and mix physiological saline at a flow rate of 0 to 0.5 times into plasma-poor blood.
また、本発明の膜型採漿法は、静脈に採血留置針を穿刺
して血液を体外に流出させ、抗凝血剤混合部においてこ
の血液に抗凝血剤を添加・混合して抗凝血化血液とし、
模型血漿分離器に抗凝血化血液を流入させて血漿を分離
して血漿容器に捕集し、次に、模型血漿分離器から流出
した乏血漿の血液に、分離した血漿の流量の0〜0,5
倍流量の生理食塩水を導入・混合し、次いて別の静脈に
穿刺した返血留置針を通じて乏血漿の血液を体内に返還
することを特徴とする。In addition, in the membrane-type plasma sampling method of the present invention, a blood collection indwelling needle is punctured into a vein to drain blood out of the body, and an anticoagulant is added and mixed with the blood in an anticoagulant mixing section to prevent anticoagulation. As blood,
Anticoagulated blood flows into a model plasma separator to separate plasma and collect it in a plasma container, and then the plasma-poor blood flowing out from the model plasma separator is added to the flow rate of the separated plasma from 0 to 0,5
It is characterized by introducing and mixing double the flow rate of physiological saline, and then returning plasma-poor blood to the body through a blood return indwelling needle punctured into another vein.
次に、本発明法を実施例にて説明する。Next, the method of the present invention will be explained using examples.
本発明法において、供血者の静脈からの血°液は、採血
留置針を通じて45だl7分の血流量にて血液回路に流
入される。一方、抗凝血剤(例え、1
ばクエン酸ナトリウム液)は抗凝血剤容器から −′1
抗凝血剤導入ポンプにより流量5πt/分にて血液回路
内に導入され、混合器内にて混合され、抗凝血化血液き
なって流量50 m/′/分にてセルローストリアセテ
ート中空糸膜型血漿分離器(有効膜面積0.25 rr
?)に流入する。該血漿分離器において平均血漿流量1
8が7分にて血漿を分離し、分離された血漿は、血漿導
入路を通じてエチレン−酢酸ビニルコポリマーシート製
血漿容器に捕集される。−万、該血漿分離器がら流出し
た乏血漿の血液(赤血球濃厚液)は、分離した血漿の流
量の0〜0.5倍流量例えば平均6.4 tttlZ分
の生理食塩水と混合され、次いで別の静脈に穿刺した返
血留置針を通じて体内に返還される。In the method of the present invention, blood from a blood donor's vein flows into the blood circuit through a blood collection indwelling needle at a blood flow rate of 45 cm. On the other hand, the anticoagulant (for example, sodium citrate solution) is removed from the anticoagulant container by -'1
The anticoagulant is introduced into the blood circuit at a flow rate of 5 πt/min by an anticoagulant introduction pump, mixed in a mixer, and the anticoagulated blood is transferred to a cellulose triacetate hollow fiber membrane at a flow rate of 50 m/'/min. type plasma separator (effective membrane area 0.25 rr
? ). In the plasma separator, the average plasma flow rate 1
8 separates plasma in 7 minutes, and the separated plasma is collected in a plasma container made of ethylene-vinyl acetate copolymer sheet through a plasma introduction channel. - The plasma-poor blood (red blood cell concentrate) flowing out of the plasma separator is mixed with physiological saline at a flow rate of 0 to 0.5 times the flow rate of the separated plasma, for example, an average of 6.4 tttlZ, and then The blood is returned to the body through a blood return indwelling needle inserted into another vein.
かくして、30分の採JJIJよび同時返血によ ・す
、500 mlの血漿を捕集できた。本発明法では体外
循環血液量は150g/であった。採漿中、悪寒・戦慄
、低血圧のごとき副作用を認めなかった。また、分離血
漿は、血小板、血球片のごとき不純物の含有を認めなか
った。In this way, 500 ml of plasma could be collected after 30 minutes of blood collection and simultaneous blood return. In the method of the present invention, the amount of extracorporeally circulating blood was 150 g/. No side effects such as chills, shivering, or hypotension were observed during the sample collection. Furthermore, the separated plasma did not contain any impurities such as platelets or blood cell fragments.
く効果〉 本発明の効果を次に示す。Effect〉 The effects of the present invention are shown below.
(1) 機構が簡素化されているので、経済性にすぐれ
ている。(1) Since the mechanism is simplified, it is highly economical.
(2) 膜型血薬分離器が小型であり、採漿と同時に返
血の方式をとっているので、採漿中の体外循環血液量が
少ない。(2) Since the membrane-type blood drug separator is small and uses a method of returning blood at the same time as plasma collection, the amount of extracorporeally circulating blood during plasma collection is small.
(3) 採漿中の体外循環血液量が少なく、且つ密閉回
路方式をとっているので、副作用の発生がない。(3) Since the amount of extracorporeally circulating blood during plasma collection is small and a closed circuit system is used, no side effects occur.
(4) 膜分離により有形成分の透過を防いでいるので
、純粋な分離血漿が得られる。(4) Since membrane separation prevents permeation of formed components, pure separated plasma can be obtained.
(5)模型採漿システムは小型であり、取扱いが容易で
ある。(5) The model sample sampling system is small and easy to handle.
第1図および第2図は、本発明の模型採漿システムの実
施例の流路系を示すものである。
特許出願人
株式会社ニッショ −FIG. 1 and FIG. 2 show a flow path system of an embodiment of the model serum sampling system of the present invention. Patent applicant Nissho Co., Ltd. −
Claims (5)
、体外に流出した血液に抗凝血剤を添加して抗凝血化血
液とする抗凝血剤混合部、該抗凝血化血液から血漿を分
離する模型血漿分離器、該模型血漿分離器にて血液から
分離された血漿を捕集する血漿容器、別の静脈に穿刺し
て乏血漿の血液を体内に返還する返血留置針、模型血漿
分離器から血漿容器に血漿を導入する血漿導入路、並び
に、採血留置針・抗凝血剤混合器・模型血漿分離器・返
血留置針の順序に連通ずる血液回路からなるこ“とを特
徴とする、模型採漿システム。(1) A blood collection indwelling needle that punctures a vein and drains blood out of the body, an anticoagulant mixing unit that adds an anticoagulant to the blood that has drained out of the body to make anticoagulated blood, and the anticoagulant. A model plasma separator that separates plasma from converted blood, a plasma container that collects the plasma separated from blood by the model plasma separator, and a blood return device that returns plasma-poor blood to the body by puncturing another vein. Consists of an indwelling needle, a plasma introduction channel that introduces plasma from the model plasma separator to the plasma container, and a blood circuit that communicates with the blood collection indwelling needle, anticoagulant mixer, model plasma separator, and blood return indwelling needle in this order. A model serum collection system featuring this feature.
導入・添加する抗凝血剤導入ポンプ、および体外に流出
した血液と添加した抗凝血剤とを混合して抗凝血化血液
として模型血漿分離器へ導入する混合器からなり、該混
合器において抗凝血化血液の流量監視および必要ならば
抗凝血化血液を行なって抗凝血剤導入ポンプの流量を調
節することを特徴とする特許請求の範囲第1項記載の模
型採漿システム。(2) The anticoagulant mixing unit includes an anticoagulant introduction pump that introduces and adds a required flow rate of anticoagulant to the blood, and an anticoagulant mixing unit that mixes the blood that has flowed out of the body and the added anticoagulant. It consists of a mixer that introduces anticoagulated blood into a model plasma separator, in which the flow rate of anticoagulated blood is monitored and, if necessary, anticoagulated blood is carried out to adjust the flow rate of the anticoagulant introduction pump. 2. The model sample sampling system according to claim 1, wherein the model sample sampling system is configured to adjust:
を有する高分子膜からなることを特徴とする特許請求の
範囲第1項記載の模型採漿システム。(3) The model plasma collection system according to claim 1, wherein the model plasma separator is made of a polymer membrane having a membrane pore diameter of 0.1 to 1 micron.
ポンプおよび必要ならば補充液加温器からなり、血漿導
入路における血漿流量の0〜0、5倍の流量の生理食塩
水を、乏血漿の血液に導入・混合できる補充液導入部を
設けて・なることを特徴とする特許請求の範囲第1項記
載の模型採漿システム。(4) Between the model plasma separator and the blood return indwelling needle, it consists of a replenisher pump and, if necessary, a replenisher warmer, and physiological saline at a flow rate of 0 to 0.5 times the plasma flow rate in the plasma introduction channel. 2. The model plasma collection system according to claim 1, further comprising a replenisher introduction section that can introduce and mix water with the plasma-poor blood.
させ、抗凝血剤混合部においてこの血液に抗凝血剤を添
加・混合して抗凝血化血液とし、模型血漿分離器に抗凝
血化血液を流入させて血漿を分離して血漿容器に捕集し
、次に模型血漿分離器から流出した乏血漿の血液に分離
した血漿の流量のO−0,5倍流量の生理食塩水を導入
・混合し、次いで別の静脈に穿刺した返血留置針を通じ
て乏血漿の血液を体内に返還することを特徴とする、成
型採漿法。(5) Puncture a blood collection indwelling needle into a vein to allow blood to flow out of the body, add and mix an anticoagulant to this blood in an anticoagulant mixing section to make anticoagulated blood, and use a model plasma separator. anticoagulated blood flows into the plasma separator, plasma is separated and collected in a plasma container, and then the plasma-poor blood flowing out from the model plasma separator is divided into O-0.5 times the flow rate of the separated plasma. A molded serum collection method characterized by introducing and mixing physiological saline, and then returning plasma-poor blood into the body through a blood return indwelling needle punctured in another vein.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59112453A JPS60256464A (en) | 1984-05-31 | 1984-05-31 | Membrane type serum sampling system and method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59112453A JPS60256464A (en) | 1984-05-31 | 1984-05-31 | Membrane type serum sampling system and method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS60256464A true JPS60256464A (en) | 1985-12-18 |
Family
ID=14587012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP59112453A Pending JPS60256464A (en) | 1984-05-31 | 1984-05-31 | Membrane type serum sampling system and method |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS60256464A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58206758A (en) * | 1982-05-28 | 1983-12-02 | 株式会社クラレ | plasma separator |
JPS60135066A (en) * | 1983-12-26 | 1985-07-18 | 株式会社ニツシヨ− | Drainage system |
-
1984
- 1984-05-31 JP JP59112453A patent/JPS60256464A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58206758A (en) * | 1982-05-28 | 1983-12-02 | 株式会社クラレ | plasma separator |
JPS60135066A (en) * | 1983-12-26 | 1985-07-18 | 株式会社ニツシヨ− | Drainage system |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3986506A (en) | Apparatus for separation of cryoprecipitate from blood plasma and method | |
US4898573A (en) | Blood components collector unit | |
US4655742A (en) | Process/apparatus for the withdrawal/return of body fluids | |
US5407425A (en) | System for the collecting and retransfusion of autologous blood | |
US4025618A (en) | Method for separation of cryoprecipitate from blook plasma | |
JPS61175566A (en) | Separator for light component and heavy component of liquid specimen | |
JPS6410230B2 (en) | ||
CA2127403A1 (en) | Apheresis system | |
JP2888590B2 (en) | Equipment for plasma and packed red blood cell collection | |
JPS63226364A (en) | Blood component sampling set | |
IL47945A (en) | Method and apparatus for the separation of cryprecipitate separation of cryoprecipitate from blood plasma | |
CN110279423B (en) | Vacuum blood collection tube for separating serum and method thereof | |
JPS60256464A (en) | Membrane type serum sampling system and method | |
JP2533059B2 (en) | Plasma collection method | |
JP3005019B2 (en) | Kit and method for preparing cryopreserved blood | |
JPH0112500B2 (en) | ||
JPS5921813Y2 (en) | Blood granulocyte collection filter | |
JPH056994Y2 (en) | ||
JPH0584338U (en) | Blood component separation circuit | |
JPS60261461A (en) | Single needle type membrane serum sampling system | |
JPH0526506B2 (en) | ||
JPS6219177A (en) | blood processing equipment | |
JPS60256466A (en) | plasma collection device | |
JPH0415699B2 (en) | ||
JPH0586235B2 (en) |